Related Experiment Video
Updated: Jun 9, 2026
08:16
Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
OGA inhibition by GlcNAc-selenazoline
Eun Ju Kim1, Dona C Love, Etzer Darout
1Department of Science Education-Chemistry Major, Daegu University, Gyeongbuk 712-714, Republic of Korea.
Bioorganic & Medicinal Chemistry
|September 9, 2010
Summary
A selenium-based O-GlcNAcase inhibitor, selenazoline, is weaker in direct assays but shows similar cell-based effects to its sulfur analog. Both compounds effectively induce hyper-O-GlcNAc-ylation and reduce glucose transporter 4 translocation in adipocytes.
Area of Science:
- Biochemistry
- Cellular Biology
- Drug Discovery
Background:
- O-GlcNAcase (OGA) is a key enzyme in regulating O-GlcNAcylation, a post-translational modification.
- GlcNAc-thiazoline is a potent OGA inhibitor, but its properties in cellular models require further investigation.
- Understanding the impact of structural modifications on OGA inhibitors is crucial for developing new therapeutics.
Purpose of the Study:
- To compare the activity of a novel selenazoline-based OGA inhibitor with its known sulfur-based counterpart (GlcNAc-thiazoline).
- To investigate the cellular effects of selenazoline, specifically its ability to induce hyper-O-GlcNAc-ylation and affect glucose uptake.
- To evaluate the potential of selenazoline as an OGA inhibitor in a cellular context.
Main Methods:
- Direct enzyme inhibition assays to determine OGA inhibitory potency.
- Cellular assays in human cells to assess the induction of hyper-O-GlcNAc-ylation.
- Experiments in differentiated 3T3 adipocytes to measure insulin-stimulated translocation of glucose transporter 4.
Main Results:
- Selenazoline demonstrated significantly weaker inhibitory activity against OGA in direct enzymatic assays compared to GlcNAc-thiazoline.
- In human cells, selenazoline exhibited a comparable ability to induce hyper-O-GlcNAc-ylation as GlcNAc-thiazoline.
- Both compounds similarly reduced the translocation of glucose transporter 4 in response to insulin in differentiated 3T3 adipocytes.
Conclusions:
- Despite lower direct enzyme inhibition, selenazoline effectively mimics the cellular effects of GlcNAc-thiazoline.
- The chalcogen atom (selenium vs. sulfur) has a differential impact on direct OGA inhibition versus cellular activity.
- Selenazoline represents a viable alternative OGA inhibitor for cellular studies and potential therapeutic development.
Related Concept Videos
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...